Document:

cwh_Ex4_2

		
			Exhibit 4.2
		

		
			DESCRIPTION OF CAPITAL STOCK
		

		
			General
		

		
			The following description of the capital stock of Camping World Holdings, Inc. (the “Company,” “we,” “us,” and “our”) and certain provisions of our amended and restated certificate of incorporation (our “certificate”) and amended and restated bylaws (our “bylaws”) are summaries and are qualified in their entirety by reference to the full text of our amended and restated certificate of incorporation and amended and restated bylaws, each of which is filed as an exhibit to this Annual Report on Form 10-K, and applicable provisions of the General Corporation Law of the State of Delaware (the “DGCL”).
		

		
			Our certificate authorizes capital stock consisting of:
		

			
	
			
				 ·
			

			
	
			
			250,000,000 shares of Class A common stock, par value $0.01 per share;

			
	
			
				 ·
			

			
	
			
			75,000,000 shares of Class B common stock, par value $0.0001 per share;

			
	
			
				 ·
			

			
	
			
			one share of Class C common stock, par value $0.0001 per share; and

			
	
			
				 ·
			

			
	
			
			20,000,000 shares of preferred stock, par value $0.01 per share.

		
			Certain provisions of our certificate and our bylaws summarized below may be deemed to have an anti-takeover effect and may delay or prevent a tender offer or takeover attempt that a stockholder might consider to be in its best interest, including those attempts that might result in a premium over the market price for the shares of common stock.
		

		
			Class A Common Stock
		

		
			Holders of shares of our Class A common stock are entitled to one vote for each share held of record on all matters submitted to a vote of the holders of Class A common stock, whether voting separately as a class or otherwise. The holders of our Class A common stock do not have cumulative voting rights in the election of directors. Holders of shares of our Class A common stock, Class B common stock and Class C common stock vote together as a single class (or, if any holders of shares of preferred stock are entitled to vote together with the holders of Common Stock, as a single class with such holders of preferred stock) on all matters presented to our stockholders for their vote or approval, except for certain amendments to our certificate described below or as otherwise required by applicable law or the certificate.
		

		
			Holders of shares of our Class A common stock are entitled to receive dividends when and if declared by our board of directors out of funds legally available therefor, subject to any statutory or contractual restrictions on the payment of dividends and to any restrictions on the payment of dividends imposed by the terms of any outstanding preferred stock.
		

		
			Upon our dissolution or liquidation, after payment in full of all amounts required to be paid to creditors and to the holders of preferred stock having liquidation preferences, if any, the holders of shares of our Class A common stock, Class B common stock and Class C common stock will be entitled to receive pro rata our remaining assets available for distribution in proportion to the number of shares held by each such stockholder; provided, that the holders of shares of Class B common stock and Class C common stock will be entitled to receive $0.01 per share, and upon receiving such amount, the holders of shares of Class B common stock and Class C common stock, as such, shall not be entitled to receive any other assets or funds of the Company.
		

		
			
		

		
			

		 

		

		
			Holders of shares of our Class A common stock do not have preemptive, subscription, redemption or conversion rights. There will be no redemption or sinking fund provisions applicable to the Class A common stock.
		

		
			Class B Common Stock
		

		
			Each share of our Class B common stock entitles its holders to one vote per share on all matters submitted to a vote of the holders of Class B common stock, whether voting separately as a class or otherwise; provided that, for as long as ML Acquisition Company, LLC, a Delaware limited liability company ("ML Acquisition"), and its Permitted Transferees (as defined in the certificate) of the common units of CWGS Enterprises, LLC, a Delaware limited liability company ("CWGS LLC")  (ML Acquisition and such Permitted Transferees collectively, the "ML Related Parties"), directly or indirectly, beneficially own in the aggregate 27.5% or more of all of the outstanding common units of CWGS LLC, the shares of our Class B common stock held by the ML Related Parties entitle the ML Related Parties to the number of votes necessary such that the ML Related Parties, in the aggregate, cast 47% of the total votes eligible to be cast by all of our stockholders on all matters presented to a vote of our stockholders generally. The holders of shares of our Class B common stock do not have cumulative voting rights in the election of directors.
		

		
			Additional shares of Class B common stock may be issued only to the extent necessary to maintain a one-to-one ratio between the number of common units of CWGS LLC held by the ML Related Parties and CVRV Acquisition LLC (“Crestview” and its Permitted Transferees, “Crestview Holders” and together with the ML Related Parties, the “Permitted Class B Owners”) and the number of shares of Class B common stock issued to the Permitted Class B Owners. Shares of Class B common stock are transferable only to the extent provided by the Amended and Restated Limited Liability Company Agreement of CWGS LLC, dated March 8, 2016 (the “LLC Agreement”) and must be transferred together with an equal number of common units of CWGS LLC.
		

		
			Holders of our Class B common stock do not have any right to receive dividends. Additionally, holders of shares of our Class B common stock do not have preemptive, subscription, redemption or conversion rights. There are no redemption or sinking fund provisions applicable to the Class B common stock.
		

		
			Class C Common Stock
		

		
			The one share of our Class C common stock entitles its holder, ML RV Group, LLC, a Delaware limited liability company ("ML RV Group"), to the number of votes necessary such that the holder casts 5% of the total votes eligible to be cast by all of our stockholders on all matters presented to our stockholders generally for as long as there is no Class C Change of Control (as defined below). Upon a Class C Change of Control, our Class C common stock shall no longer have any voting rights, such share of our Class C common stock will be cancelled for no consideration and will be retired, and we will not reissue such share of Class C common stock.
		

		
			For purposes of our Class C common stock, "Class C Change of Control" means the occurrence of any of the following events: (1) any "person" or "group" (within the meaning of Sections 13(d) and 14(d) of the Exchange Act (excluding the ML Related Parties and Crestview)) becomes the beneficial owner of securities of the Company representing more than fifty percent (50%) of the combined voting power of our then outstanding voting securities; (2) our stockholders approve a plan of complete liquidation or dissolution of the Company; (3) the merger or consolidation of the Company with any other
		

		
			
		

		
			

		 

		

		
			person, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than fifty percent (50%) of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation; (4) we cease to be the sole managing member of CWGS LLC; or (5) the ML Related Parties directly or indirectly, beneficially own in the aggregate, less than 27.5% of all of the outstanding common units of CWGS LLC. Notwithstanding the foregoing, a "Class C Change of Control" shall not be deemed to have occurred by virtue of the consummation of any transaction or series of integrated transactions immediately following which the record holders of the Class A common stock, Class B common stock and Class C common stock immediately prior to such transaction or series of transactions continue to have substantially the same proportionate ownership in and voting control over, and own substantially all of the shares of, an entity which owns all or substantially all of the assets of the Company immediately following such transaction or series of transactions.
		

		
			The holder of the one share of our Class C common stock does not have cumulative voting rights in the election of directors. The one share of our Class C common stock is not transferable.
		

		
			The holder of the one share of our Class C common stock does not have any right to receive dividends. Additionally, the holder of the one share of our Class C common stock does not have preemptive, subscription, redemption or conversion rights. There are not any redemption or sinking fund provisions applicable to the Class C common stock.
		

		
			Preferred Stock
		

		
			The total of our authorized shares of preferred stock is 20,000,000 shares. We have no shares of preferred stock outstanding.
		

		
			Under the terms of our certificate, our board of directors is authorized to direct us to issue shares of preferred stock in one or more series without stockholder approval. Our board of directors has the discretion to determine the powers, designations, preferences and relative, participating, optional or other special rights, and qualifications, limitations or restrictions, of each series of preferred stock.
		

		
			The purpose of authorizing our board of directors to issue preferred stock and determine its rights and preferences is to eliminate delays associated with a stockholder vote on specific issuances. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions, future financings and other corporate purposes, could have the effect of making it more difficult for a third-party to acquire, or could discourage a third-party from seeking to acquire, a majority of our outstanding voting stock. Additionally, the issuance of preferred stock may adversely affect the holders of our Class A common stock by restricting dividends on the Class A common stock, diluting the voting power of the Class A common stock or subordinating the liquidation rights of the Class A common stock. As a result of these or other factors, the issuance of preferred stock could have an adverse impact on the market price of our Class A common stock.
		

		
			Forum Selection
		

		
			Our certificate provides that unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware will, to the fullest extent permitted by applicable law, be the sole and exclusive forum for (i) any derivative action or proceeding brought on our behalf; (ii) any
		

		
			
		

		
			

		 

		

		
			action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers or other employees to us or our stockholders; (iii) any action asserting a claim arising pursuant to any provision of the DGCL, as to which the DGCL confers jurisdiction on the Court of Chancery; or (iv) any action asserting a claim against us, any director or our officers or employees that is governed by the internal affairs doctrine.
		

		
			Dividends
		

		
			The DGCL permits a corporation to declare and pay dividends out of "surplus" or, if there is no "surplus," out of its net profits for the fiscal year in which the dividend is declared and/or the preceding fiscal year. "Surplus" is defined as the excess of the net assets of the corporation over the amount determined to be the capital of the corporation by the board of directors. The capital of the corporation is typically calculated to be (and cannot be less than) the aggregate par value of all issued shares of capital stock. Net assets equals the fair value of the total assets minus total liabilities. The DGCL also provides that dividends may not be paid out of net profits if, after the payment of the dividend, capital is less than the capital represented by the outstanding stock of all classes having a preference upon the distribution of assets.
		

		
			Declaration and payment of any dividend will be subject to the discretion of our board of directors. The time and amount of dividends will be dependent upon our financial condition, operations, cash requirements and availability, debt repayment obligations, capital expenditure needs and restrictions in our debt instruments, industry trends, the provisions of Delaware law affecting the payment of distributions to stockholders and any other factors our board of directors may consider relevant.
		

		
			Anti-Takeover Provisions
		

		
			Our certificate and bylaws contain provisions that may delay, defer or discourage another party from acquiring control of us. We expect that these provisions, which are summarized below, will discourage coercive takeover practices or inadequate takeover bids. These provisions are also designed to encourage persons seeking to acquire control of us to first negotiate with our board of directors, which we believe may result in an improvement of the terms of any such acquisition in favor of our stockholders. However, they also give our board of directors the power to discourage acquisitions that some stockholders may favor.
		

		
			Authorized but unissued shares.
		

		
			The authorized but unissued shares of our common stock and our preferred stock are available for future issuance without stockholder approval, subject to any limitations imposed by the listing standards of the NYSE. These additional shares may be used for a variety of corporate finance transactions, acquisitions, employee benefit plans and funding of redemptions of common units of CWGS LLC. The existence of authorized but unissued and unreserved common stock and preferred stock could make more difficult or discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise.
		

		
			Classified board of directors. 
		

		
			Our certificate provides that our board of directors is divided into three classes, with the classes as nearly equal in number as possible and each class serving three-year staggered terms.  Directors may only be removed from our board of directors for cause by the affirmative vote of the holders of a majority of the voting power of all of the outstanding shares of stock of the Company which are present in person or by proxy and entitled to vote thereon, except as provided in Section 2(b) of the voting agreement we 
		

		
			
		

		
			

		 

		

		
			entered into with ML Acquisition, entities affiliated with Crestview, and ML RV Group (the “Voting Agreement”). These provisions may have the effect of deferring, delaying or discouraging hostile takeovers, or changes in control of us or our management.
		

		
			Stockholder action by written consent. 
		

		
			Our certificate provides that any action required or permitted to be taken by our stockholders at an annual meeting or special meeting of stockholders may be taken without a meeting, without prior notice and without a vote, if a written consent is signed by the holders of our outstanding shares of common stock representing not less than the minimum number of votes that would be necessary to authorize such action at a meeting at which all outstanding shares of common stock entitled to vote thereon.  Subject to the rights of any series of Preferred Stock permitting the holders of such series of Preferred Stock to act by written consent, at such time as the ML Related Parties, directly or indirectly, beneficially own in the aggregate, less than 27.5% of all of the outstanding common units of CWGS LLC, our certificate and our bylaws provide that, any action required or permitted to be taken by our stockholders at an annual meeting or special meeting of stockholders may not be taken by written consent in lieu of a meeting.
		

		
			Special meetings of stockholders. 
		

		
			Our bylaws provide that a majority of our stockholders or a majority of our board of directors may call special meetings of our stockholders, and at such time as the ML Related Parties, directly or indirectly, beneficially own in the aggregate, less than 27.5% of all of the outstanding common units of CWGS LLC, our bylaws provide that, except as otherwise required by law, only a majority of our board of directors may call special meetings of our stockholders.
		

		
			Advance notice requirements for stockholder proposals and director nominations. 
		

		
			In addition, our bylaws provide for an advance notice procedure for stockholder proposals to be brought before an annual meeting of stockholders, including proposed nominations of candidates for election to our board of directors. In order for any matter to be "properly brought" before a meeting, a stockholder will have to comply with advance notice and duration of ownership requirements and provide us with certain information. Stockholders at an annual meeting may only consider proposals or nominations specified in the notice of meeting or brought before the meeting by or at the direction of our board of directors or by a qualified stockholder of record on the record date for the meeting, who is entitled to vote at the meeting and who has delivered timely written notice in proper form to our secretary of the stockholder's intention to bring such business before the meeting. These provisions could have the effect of delaying stockholder actions that are favored by the holders of a majority of our outstanding voting securities until the next stockholder meeting.
		

		
			Amendment of certificate of incorporation or bylaws. 
		

		
			The DGCL provides generally that the affirmative vote of a majority of the shares entitled to vote on any matter is required to amend a corporation's certificate of incorporation or bylaws, unless a corporation's certificate of incorporation or bylaws, as the case may be, requires a greater percentage. Subject to the provisions of the Voting Agreement, our bylaws may be amended or repealed by a majority vote of our board of directors or by the affirmative vote of a majority of the votes which all our stockholders would be eligible to cast in an election of directors. At such time as the ML Related Parties, directly or indirectly, beneficially own in the aggregate, less than 27.5% of all of the outstanding common units of CWGS LLC, our bylaws may be amended or repealed by a majority vote of our board of directors or by the affirmative vote of the holders of at least 66 2/3% of the votes which all our stockholders would
		

		
			
		

		
			

		 

		

		
			be eligible to cast in any annual election of directors. In addition, the affirmative vote of a majority of the votes which all our stockholders would be eligible to cast in an election of directors will be required to amend or repeal or to adopt any provisions inconsistent with any of the provisions of our certificate, and any amendment of our certificate that gives holders of our Class B common stock or the holder of our Class C common stock (i) any rights to receive dividends or any other kind of distribution, (ii) any right to convert into or be exchanged for Class A common stock or (iii) any other economic rights will require, in addition to stockholder approval, the affirmative vote of the holders of a majority of shares of our Class A common stock voting separately as a class. At such time as the ML Related Parties, directly or indirectly, own in the aggregate, less than 27.5% of all of the outstanding common units of CWGS LLC, the affirmative vote of the holders of at least 66 2/3% of the votes which all our stockholders would be entitled to cast in any election of directors will be required to amend or repeal or to adopt any provisions contained in our certificate described above.
		

		
			Section 203 of the DGCL. 
		

		
			We have opted out of Section 203 of the DGCL. However, our certificate contains provisions that are similar to Section 203. Specifically, our certificate provides that, subject to certain exceptions, we will not be able to engage in a "business combination" with any "interested stockholder" for three years following the date that the person became an interested stockholder, unless the interested stockholder attained such status with the approval of our board of directors or unless the business combination is approved by the board of directors and authorized at an annual or special meeting of stockholders by the affirmative vote of at least 66 2/3% of the outstanding shares of capital stock of the Company that is not owned by such interested stockholder. A "business combination" includes, among other things, a merger or consolidation involving us and the "interested stockholder" and the sale of more than 10% of our assets. In general, an "interested stockholder" is any entity or person beneficially owning 15% or more of our outstanding voting stock and any entity or person affiliated with or controlling or controlled by such entity or person. However, in our case, ML Acquisition and Crestview and any of their respective affiliates and any of their respective direct or indirect transferees receiving 15% or more of our outstanding voting stock will not be deemed to be interested stockholders regardless of the percentage of our outstanding voting stock owned by them, and accordingly will not be subject to such restrictions.
		

		
			Limitations on Liability and Indemnification of Officers and Directors
		

		
			Our certificate and bylaws provide indemnification for our directors and officers to the fullest extent permitted by the DGCL. We have entered into indemnification agreements with each of our directors and certain of our officers that may, in some cases, be broader than the specific indemnification provisions contained under Delaware law. In addition, as permitted by Delaware law, our certificate includes provisions that eliminate the personal liability of our directors for monetary damages resulting from breaches of certain fiduciary duties as a director. The effect of this provision is to restrict our rights and the rights of our stockholders in derivative suits to recover monetary damages against a director for breach of fiduciary duties as a director.
		

		
			These provisions may be held not to be enforceable for violations of the federal securities laws of the United States.
		

		
			Corporate Opportunity Doctrine
		

		
			Delaware law permits corporations to adopt provisions renouncing any interest or expectancy in certain opportunities that are presented to the corporation or its officers, directors or stockholders. Our certificate, to the maximum extent permitted from time to time by Delaware law, renounces any interest
		

		
			
		

		
			

		 

		

		
			or expectancy that we have in, or right to be offered an opportunity to participate in, specified business opportunities that are from time to time presented to certain of our officers, directors or stockholders or their respective affiliates, other than those officers, directors, stockholders or affiliates acting in their capacity as our employee or director. Our certificate provides that, to the fullest extent permitted by law, any director or stockholder who is not employed by us or our affiliates will not have any duty to refrain from (1) engaging in a corporate opportunity in the same or similar lines of business in which we or our affiliates now engage or propose to engage or (2) otherwise competing with us or our affiliates. In addition, to the fullest extent permitted by law, in the event that any director or stockholder, other than director or stockholder who is not employed by us or our affiliates acting in their capacity as our director or stockholder who is not employed by us or our affiliates, acquires knowledge of a potential transaction or other business opportunity which may be a corporate opportunity for itself or himself or its or his affiliates or for us or our affiliates, such person will have no duty to communicate or offer such transaction or business opportunity to us or any of our affiliates and they may take any such opportunity for themselves or offer it to another person or entity. To the fullest extent permitted by Delaware law, no potential transaction or business opportunity may be deemed to be a corporate opportunity of the corporation or its subsidiaries unless (a) we or our subsidiaries would be permitted to undertake such transaction or opportunity in accordance with our certificate, (b) we or our subsidiaries, at such time have sufficient financial resources to undertake such transaction or opportunity, (c) we have an interest or expectancy in such transaction or opportunity and (d) such transaction or opportunity would be in the same or similar line of our or our subsidiaries' business in which we or our subsidiaries are engaged or a line of business that is reasonably related to, or a reasonable extension of, such line of business. Our certificate does not renounce our interest in any business opportunity that is expressly offered to an employee director or employee in his or her capacity as a director or employee of the Company. To the fullest extent permitted by law, no business opportunity will be deemed to be a potential corporate opportunity for us unless we would be permitted to undertake the opportunity under our certificate, we have sufficient financial resources to undertake the opportunity and the opportunity would be in line with our business.
		

		
			Dissenters' Rights of Appraisal and Payment
		

		
			Under the DGCL, with certain exceptions, our stockholders have appraisal rights in connection with a merger or consolidation of the Company. Pursuant to the DGCL, stockholders who properly request and perfect appraisal rights in connection with such merger or consolidation will have the right to receive payment of the fair value of their shares as determined by the Delaware Court of Chancery.
		

		
			Stockholders' Derivative Actions
		

		
			Under the DGCL, any of our stockholders may bring an action in our name to procure a judgment in our favor, also known as a derivative action, provided that the stockholder bringing the action is a holder of our shares at the time of the transaction to which the action relates or such stockholder's stock thereafter devolved by operation of law.
		

		
			Transfer Agent and Registrar
		

		
			The transfer agent and registrar for our Class A common stock is American Stock Transfer & Trust Company, LLC.
		

		
			Trading Symbol and Market
		

		
			Our Class A common stock is listed on the NYSE under the symbol "CWH."EX-4.1

 Exhibit 4.1 
  

 
 ORIC PHARMACEUTICALS, INC. 

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

June 4, 2019 

 TABLE OF CONTENTS 

 

													
		  				  		  		  	 	Page	 
		
	  Section 1 Definitions
	  	 	1	 
					
		  	 	1.1  	 	  		  	 Certain Definitions
	  	 	1	 
		
	  Section 2 Registration Rights
	  	 	4	 
					
		  	 	2.1  	 	  		  	 Requested Registration
	  	 	4	 
		  	 	2.2  	 	  		  	 Company Registration
	  	 	6	 
		  	 	2.3  	 	  		  	 Registration on Form S-3
	  	 	7	 
		  	 	2.4  	 	  		  	 Expenses of Registration
	  	 	8	 
		  	 	2.5  	 	  		  	 Registration Procedures
	  	 	9	 
		  	 	2.6  	 	  		  	 Indemnification
	  	 	10	 
		  	 	2.7  	 	  		  	 Information by Holder
	  	 	12	 
		  	 	2.8  	 	  		  	 Restrictions on Transfer
	  	 	12	 
		  	 	2.9  	 	  		  	 Rule 144 Reporting
	  	 	14	 
		  	 	2.10	 	  		  	 Market Stand-Off Agreement
	  	 	14	 
		  	 	2.11	 	  		  	 Delay of Registration
	  	 	15	 
		  	 	2.12	 	  		  	 Intentionally Omitted
	  	 	15	 
		  	 	2.13	 	  		  	 Limitations on Subsequent Registration Rights
	  	 	15	 
		  	 	2.14	 	  		  	 Termination of Registration Rights
	  	 	15	 
		
	  Section 3 Information Covenants Of The Company
	  	 	15	 
					
		  	 	3.1  	 	  		  	 Basic Financial Information and Inspection Rights
	  	 	15	 
		  	 	3.2  	 	  		  	 Confidentiality
	  	 	16	 
		  	 	3.3  	 	  		  	 Confidential Information and Invention Assignment Agreements
	  	 	17	 
		  	 	3.4  	 	  		  	 Stock Option Vesting
	  	 	17	 
		  	 	3.5  	 	  		  	 Right of First Refusal
	  	 	17	 
		  	 	3.6  	 	  		  	 Indemnification Agreements
	  	 	17	 
		  	 	3.7  	 	  		  	 Directors and Officers Insurance
	  	 	17	 
		  	 	3.8  	 	  		  	 Termination of Covenants
	  	 	18	 
		
	  Section 4 Right Of First Refusal
	  	 	18	 
					
		  	 	4.1  	 	  		  	 Right of First Refusal to Major Investors
	  	 	18	 
		
	  Section 5 Miscellaneous
	  	 	20	 
					
		  	 	5.1  	 	  		  	 Amendment
	  	 	20	 
		  	 	5.2  	 	  		  	 Notices
	  	 	20	 
		  	 	5.3  	 	  		  	 Governing Law
	  	 	21	 
		  	 	5.4  	 	  		  	 Successors and Assigns
	  	 	21	 
		  	 	5.5  	 	  		  	 Entire Agreement
	  	 	22	 
		  	 	5.6  	 	  		  	 Delays or Omissions
	  	 	22	 
		  	 	5.7  	 	  		  	 Severability
	  	 	22	 
		  	 	5.8  	 	  		  	 Titles and Subtitles
	  	 	22	 

													
		  	 	5.9  	 	  		  	 Counterparts
	  	 	22	 
		  	 	5.10	 	  		  	 Telecopy Execution and Delivery
	  	 	23	 
		  	 	5.11	 	  		  	 Jurisdiction; Venue
	  	 	23	 
		  	 	5.12	 	  		  	 Further Assurances
	  	 	23	 
		  	 	5.13	 	  		  	 Conflict
	  	 	23	 
		  	 	5.14	 	  		  	 Attorney’s Fees
	  	 	23	 
		  	 	5.15	 	  		  	 Aggregation of Stock
	  	 	23	 
		  	 	5.16	 	  		  	 Amendment of Prior Rights Agreement
	  	 	23	 

  
 -2- 

 ORIC PHARMACEUTICALS, INC. 

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

This Amended and Restated Investors’ Rights Agreement (this “Agreement”) is dated as of
June 4, 2019, and is between ORIC Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the persons and entities listed on Exhibit A (each, an “Investor” and collectively, the
“Investors”). 
 RECITALS 

Certain of the Investors are purchasing shares of the Company’s Series D Preferred Stock (the “Series D
Preferred Stock” and together with the Company’s Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock, the “Preferred Stock”), pursuant to that certain Series D Preferred Stock
Purchase Agreement of even date herewith, among the Company and the Investors listed on the Schedule of Investors thereto (as may be amended from time to time, the “Purchase Agreement”), and it is a condition to the closing
of the sale of the Series D Preferred Stock that the Investors and the Company execute and deliver this Agreement. 

Certain of the Investors are parties to that certain Amended and Restated Investors’ Rights Agreement dated
February 6, 2018 (the “Prior Rights Agreement”) between the Company and the Investors listed on Exhibit A thereto (the “Prior Investors”). 

The Company and the undersigned Prior Investors, representing sufficient signatory authority to amend and restate the Prior
Rights Agreement, desire to amend and restate the Prior Rights Agreement in its entirety as set forth in this Agreement. 

The parties therefore agree to amend and restate the Prior Rights Agreement in its entirety as follows: 

Section 1 
 DEFINITIONS

 1.1        Certain Definitions. As used in this Agreement, the
following terms shall have the meanings set forth below: 

(a)        “Affiliate” means, with respect to any specified
Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common control with such Person, including without limitation any general partner, managing member, officer or director of such Person or any venture
capital or other investment fund now or hereafter existing that is controlled by one or more general partners or managing members of, or shares the same management company or investment advisor with, such Person. 

(b)        “Commission” shall mean the Securities and
Exchange Commission or any other federal agency at the time administering the Securities Act (as defined below). 

(c)        “Common Stock” shall mean the Common Stock of the
Company. 

 (d)        “Exchange
Act” shall mean the Securities Exchange Act of 1934, as amended, or any similar successor federal statute and the rules and regulations thereunder, all as the same shall be in effect from time to time. 

(e)        “Holder” shall mean any Investor who holds
Registrable Securities and any holder of Registrable Securities to whom the registration rights conferred by this Agreement have been duly and validly transferred in accordance with Section 5.4 of this Agreement. 

(f)        “Indemnified Party” shall have the meaning set
forth in Section 2.6(c). 
 (g)        “Indemnifying
Party” shall have the meaning set forth in Section 2.6(c). 

(h)        “Initial Public Offering” shall mean the closing
of the Company’s first firm commitment underwritten public offering of the Company’s Common Stock registered under the Securities Act. 

(i)        “Initiating Holders” shall mean any Holder or
Holders who in the aggregate hold not less than fifty percent (50%) of the outstanding Registrable Securities. 

(j)        “Major Investor” shall have the meaning set forth
in Section 3.1(a). 
 (k)        “New Securities”
shall have the meaning set forth in Section 4.1(b). 

(l)        “Other Selling Stockholders” shall mean persons
other than Holders who, by virtue of agreements with the Company, are entitled to include their Other Shares in certain registrations hereunder. 

(m)        “Other Shares” shall mean shares of Common Stock,
other than Registrable Securities (as defined below), with respect to which registration rights have been granted. 

(n)        “Person” means any individual, corporation,
partnership, trust, limited liability company, association or other entity. 

(o)        “Purchase Agreement’ shall have the meaning set
forth in the Recitals. 
 (p)        “Registrable
Securities” shall mean (i) shares of Common Stock issued or issuable pursuant to the conversion of the Shares and (ii) any Common Stock issued as a dividend or other distribution with respect to or in exchange for or in
replacement of the shares referenced in (i) above; provided, however, that Registrable Securities shall not include any shares of Common Stock described in clause (i) or (ii) above which have previously been registered or which have been
sold to the public either pursuant to a registration statement or Rule 144, or which have been sold in a private transaction in which the transferor’s rights under this Agreement are not validly assigned in accordance with this Agreement. 

(q)        The terms “register,”
“registered” and “registration” shall refer to a registration effected by preparing and filing a registration statement in compliance with the Securities

  
 -2- 

 
Act (as defined below) and applicable rules and regulations thereunder, and the declaration or ordering of the effectiveness of such registration statement. 

(r)        “Registration Expenses” shall mean all expenses
incurred in effecting any registration pursuant to this Agreement, including, without limitation, all registration, qualification, and filing fees, printing expenses, escrow fees, fees and disbursements of counsel for the Company, reasonable
documented fees and disbursements of one special counsel for the Holders not to exceed $50,000, blue sky fees and expenses, and expenses of any regular or special audits incident to or required by any such registration, but shall not include Selling
Expenses, and the compensation of regular employees of the Company, which shall be paid in any event by the Company. 

(s)        “Requisite Holders” means the holders of at least
a majority of the then outstanding Registrable Securities. 

(t)        “Restated Certificate” shall mean the
Company’s Amended and Restated Certificate of Incorporation, as the same may be amended from time to time. 

(u)        “Restricted Securities” shall mean any Registrable
Securities required to bear the first legend set forth in Section 2.8(b). 

(v)        “Right of First Refusal and
Co-Sale Agreement” shall mean that certain Amended and Restated Right of First Refusal and Co-Sale Agreement, dated as of even date herewith, by and between
the Company and the individuals and entities party thereto. 

(w)        “Rule 144” shall mean Rule 144 as promulgated by
the Commission under the Securities Act, as such Rule may be amended from time to time, or any similar successor rule that may be promulgated by the Commission. 

(x)        “Rule 145” shall mean Rule 145 as promulgated by
the Commission under the Securities Act, as such Rule may be amended from time to time, or any similar successor rule that may be promulgated by the Commission 

(y)        “Rule 415” shall mean Rule 415 as promulgated by
the Commission under the Securities Act, as such Rule may be amended from time to time, or any similar successor rule that may be promulgated by the Commission. 

(z)        “Securities Act” shall mean the Securities Act of
1933, as amended, or any similar successor federal statute and the rules and regulations thereunder, all as the same shall be in effect from time to time. 

(aa)        “Selling Expenses” shall mean all underwriting
discounts, selling commissions and stock transfer taxes applicable to the sale of Registrable Securities and fees and disbursements of counsel for any Holder (other than the fees and disbursements of one special counsel to the Holders included in
Registration Expenses). 
 (bb)        “Shares” shall mean
the Company’s Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, and Series D Preferred Stock. 

  
 -3- 

 Section 2 

REGISTRATION RIGHTS 

2.1        Requested Registration. 

(a)        Request for Registration.  Subject to the
conditions set forth in this Section 2.1, if the Company shall receive from Initiating Holders a written request signed by such Initiating Holders that the Company effect any registration with respect to all or a part of the Registrable
Securities (such request shall state the number of shares of Registrable Securities to be disposed of and the intended methods of disposition of such shares by such Initiating Holders), the Company will: 

(i)        promptly give written notice of the proposed registration to all other
Holders; and 
 (ii)        as soon as practicable, file and use its commercially
reasonable efforts to effect such registration (including, without limitation, filing post-effective amendments, appropriate qualifications under applicable blue sky or other state securities laws, and appropriate compliance with the Securities Act)
and to permit or facilitate the sale and distribution of all or such portion of such Registrable Securities as are specified in such request, together with all or such portion of the Registrable Securities of any Holder or Holders joining in such
request as are specified in a written request received by the Company within twenty (20) days after such written notice from the Company is mailed or delivered. 

(b)        Limitations on Requested
Registration.    The Company shall not be obligated to effect, or to take any action to effect, any such registration pursuant to this Section 2.1: 

(i)        Prior to the earlier of (A) the five (5) year anniversary of the
date of this Agreement or (B) one hundred eighty (180) days following the effective date of the first registration statement filed by the Company covering an underwritten offering of any of its securities to the general public (or the
earlier date on which all market stand off agreements applicable to the offering have terminated); 

(ii)        If the Initiating Holders, together with the holders of any other
securities of the Company entitled to inclusion in such registration statement, propose to sell Registrable Securities and such other securities (if any) the aggregate gross proceeds of which (before deduction for underwriter’s discounts and
expenses related to the issuance) are less than $10,000,000; 
 (iii)        In any
particular jurisdiction in which the Company would be required to execute a general consent to service of process in effecting such registration, qualification, or compliance, unless the Company is already subject to service in such jurisdiction and
except as may be required by the Securities Act; 
 (iv)        After the Company
has effected two (2) such registrations pursuant to this Section 2.1 (and such registrations have been declared or ordered effective); 

  
 -4- 

 (v)        During the period
starting with the date sixty (60) days prior to the Company’s good faith estimate of the date of filing of, and ending on a date one hundred eighty (180) days after the effective date (or the earlier date on which all market stand off
agreements applicable to the offering have terminated) of, a Company-initiated registration; provided that the Company is actively employing in good faith commercially reasonable efforts to cause such registration statement to become effective; or

 (vi)        If the Initiating Holders propose to dispose of shares of
Registrable Securities that may be registered on Form S-3 pursuant to a request made under Section 2.3. 

(c)        Deferral.  If (i) in the good faith judgment
of the Board of Directors of the Company, the filing of a registration statement covering the Registrable Securities would be materially detrimental to the Company and the Board of Directors of the Company concludes, as a result, that it is in the
best interests of the Company to defer the filing of such registration statement at such time, and (ii) the Company shall furnish to such Holders a certificate signed by the President of the Company stating that in the good faith judgment of
the Board of Directors of the Company, it would be materially detrimental to the Company for such registration statement to be filed in the near future and that it is, therefore, in the best interests of the Company to defer the filing of such
registration statement, then (in addition to the limitations set forth in Section 2.1(b)(v) above) the Company shall have the right to defer such filing for a period of not more than ninety (90) days after receipt of the request of the
Initiating Holders, and, provided further, that the Company shall not defer its obligation in this manner more than once in any twelve-month period. 

(d)        Underwriting.    If the Initiating
Holders intend to distribute the Registrable Securities covered by their request by means of an underwriting, they shall so advise the Company as a part of their request made pursuant to this Section 2.1 and the Company shall include such
information in the written notice given pursuant to 2.1(a)(i). In such event, the right of any Holder to include all or any portion of its Registrable Securities in such registration pursuant to this Section 2.1 shall be conditioned upon such
Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities to the extent provided herein. If the Company shall request inclusion in any registration pursuant to Section 2.1 of securities
being sold for its own account, or if other persons shall request inclusion in any registration pursuant to Section 2.1, the Initiating Holders shall, on behalf of all Holders, offer to include such securities in the underwriting and such offer
shall be conditioned upon the participation of the Company or such other persons in such underwriting and the inclusion of the Company’s and such person’s other securities of the Company and their acceptance of the further applicable
provisions of this Section 2 (including Section 2.10). The Company shall (together with all Holders and other persons proposing to distribute their securities through such underwriting) enter into an underwriting agreement in customary
form with the representative of the underwriter or underwriters selected for such underwriting by the Company, which underwriters are reasonably acceptable to a
majority-in-interest of the Initiating Holders. 

Notwithstanding any other provision of this Section 2.1, if the underwriters advise the Initiating Holders in writing
that marketing factors require a limitation on the number of shares to be underwritten, the number of Registrable Securities and Other Shares that may be so included shall be allocated as follows: (i) first, among all Holders requesting to
include Registrable Securities in such registration statement based on the pro rata percentage of Registrable Securities held by such Holders, 

  
 -5- 

 
assuming conversion; (ii) second, to the Other Selling Stockholders; and (iii) third, to the Company, which the Company may allocate, at its discretion, for its own account, or for the
account of other holders or employees of the Company. 
 If a person who has requested inclusion in such registration as
provided above does not agree to the terms of any such underwriting, such person shall be excluded therefrom by written notice from the Company, the underwriter or the Initiating Holders. The securities so excluded shall also be withdrawn from
registration. Any Registrable Securities or other securities excluded or withdrawn from such underwriting shall also be withdrawn from such registration. If shares are so withdrawn from the registration and if the number of shares to be included in
such registration was previously reduced as a result of marketing factors pursuant to this Section 2.1(d), then the Company shall then offer to all Holders and Other Selling Stockholders who have retained rights to include securities in the
registration the right to include additional Registrable Securities or Other Shares in the registration in an aggregate amount equal to the number of shares so withdrawn, with such shares to be allocated among such Holders and Other Selling
Stockholders requesting additional inclusion, as set forth above. 

2.2        Company Registration. 

(a)        Company Registration.    If the Company
shall determine to register any of its securities either for its own account or the account of a security holder or holders, other than a registration pursuant to Section 2.1 or 2.3, a registration relating solely to employee benefit plans, a
registration relating to the offer and sale of debt securities, a registration relating to a corporate reorganization or other Rule 145 transaction, or a registration on any registration form that does not permit secondary sales, the Company will:

 (i)        promptly give written notice of the proposed registration to all
Holders; and 
 (ii)        use its commercially reasonable efforts to include in
such registration (and any related qualification under blue sky laws or other compliance), except as set forth in Section 2.2(b) below, and in any underwriting involved therein, all of such Registrable Securities as are specified in a written
request or requests made by any Holder or Holders received by the Company within ten (10) days after such written notice from the Company is mailed or delivered. Such written request may specify all or a part of a Holder’s Registrable
Securities. 
 (b)        Underwriting.    If the
registration of which the Company gives notice is for a registered public offering involving an underwriting, the Company shall so advise the Holders as a part of the written notice given pursuant to Section 2.2(a)(i). In such event, the right
of any Holder to registration pursuant to this Section 2.2 shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting to the extent provided
herein. All Holders proposing to distribute their securities through such underwriting shall (together with the Company and the other holders of securities of the Company with registration rights to participate therein distributing their securities
through such underwriting) enter into an underwriting agreement in customary form with the representative of the underwriter or underwriters selected by the Company. 

  
 -6- 

 Notwithstanding any other provision of this Section 2.2, if the
underwriters advise the Company in writing that marketing factors require a limitation on the number of shares to be underwritten, the underwriters may (subject to the limitations set forth below) exclude all Registrable Securities from, or limit
the number of Registrable Securities to be included in, the registration and underwriting. The Company shall so advise all holders of securities requesting registration, and the number of shares of securities that are entitled to be included in the
registration and underwriting shall be allocated, as follows: (i) first, to the Company for securities being sold for its own account, (ii) second, to the Holders requesting to include Registrable Securities in such registration statement
based on the pro rata percentage of Registrable Securities held by such Holders, assuming conversion and (iii) third, to the other Other Selling Stockholders requesting to include Other Shares in such registration statement based on the pro
rata percentage of Other Shares held by such Other Selling Stockholders, assuming conversion. Notwithstanding the foregoing, no such reduction shall reduce the value of the Registrable Securities of the Holders included in such registration below
twenty five percent (25%) of the total value of securities included in such registration, unless (A) such offering is the Company’s Initial Public Offering, and (B) and such registration does not include shares of any other selling
stockholders (excluding shares registered for the account of the Company), in which event any or all of the Registrable Securities of the Holders may be excluded. 

If a person who has requested inclusion in such registration as provided above does not agree to the terms of any such
underwriting, such person shall also be excluded therefrom by written notice from the Company or the underwriter. The Registrable Securities or other securities so excluded shall also be withdrawn from such registration. Any Registrable Securities
or other securities excluded or withdrawn from such underwriting shall be withdrawn from such registration. If shares are so withdrawn from the registration and if the number of shares of Registrable Securities to be included in such registration
was previously reduced as a result of marketing factors pursuant to Section 2.2(b), the Company shall then offer to all persons who have retained the right to include securities in the registration the right to include additional securities in
the registration in an aggregate amount equal to the number of shares so withdrawn, with such shares to be allocated among the persons requesting additional inclusion, in the manner set forth above. 

(c)        Right to Terminate Registration.    The
Company shall have the right to terminate or withdraw any registration initiated by it under this Section 2.2 prior to the effectiveness of such registration whether or not any Holder has elected to include securities in such registration. The
Registration Expenses of any such terminated or withdrawn registration shall be borne by the Company. 

2.3        Registration on Form
S-3. 
 (a)        Request for
Form S-3 Registration.    After its Initial Public Offering, the Company shall use its commercially reasonable efforts to qualify for registration on Form S-3 or any comparable or successor form or forms. After the Company has qualified for the use of Form S-3, in addition to the rights contained in the foregoing provisions of
this Section 2 and subject to the conditions set forth in this Section 2.3, if the Company shall receive from a Holder or Holders of Registrable Securities a written request that the Company effect any registration on Form S-3 or any similar short form registration statement with respect to all or part of the Registrable Securities (such request shall state the number of shares of Registrable Securities to be disposed of and the
intended 

  
 -7- 

 
methods of disposition of such shares by such Holder or Holders), the Company will take all such action with respect to such Registrable Securities as required by Section 2.1(a)(i) and 2.1
(a)(ii). 
 (b)        Limitations on Form
S-3 Registration.    The Company shall not be obligated to effect, or take any action to effect, any such registration pursuant to this Section 2.3: 

(i)        In the circumstances described in either Sections 2.1(b)(i), 2.1(b)(iii)
or 2.1 (b)(v); 
 (ii)       If the Holders, together with the holders of any other
securities of the Company entitled to inclusion in such registration, propose to sell Registrable Securities and such other securities (if any) on Form S-3 for aggregate gross proceeds (before deduction of
underwriter’s commissions and expenses) of less than $1,000,000; or 

(iii)       If, in a given twelve-month period, the Company has effected two (2) such
registrations in such period. 

(c)        Deferral.    The provisions of
Section 2.1(c) shall apply to any registration pursuant to this Section 2.3. 

(d)        Underwriting.    If the Holders of
Registrable Securities requesting registration under this Section 2.3 intend to distribute the Registrable Securities covered by their request by means of an underwriting, the provisions of Section 2.1(d) shall apply to such registration.
Notwithstanding anything contained herein to the contrary, registrations effected pursuant to this Section 2.3 shall not be counted as requests for registration or registrations effected pursuant to Section 2.1. 

2.4        Expenses of Registration.    All
Registration Expenses incurred in connection with registrations pursuant to Sections 2.1, 2.2 and 2.3 shall be borne by the Company; provided, however, that the Company shall not be required to pay for any expenses of any registration
proceeding begun pursuant to Sections 2.1 and 2.3 if the registration request is subsequently withdrawn at the request of the Holders of a majority of the Registrable Securities to be registered or because a sufficient number of Holders shall have
withdrawn so that the minimum offering conditions set forth in Sections 2.1 and 2.3 are no longer satisfied (in which case all participating Holders shall bear such expenses pro rata among each other based on the number of Registrable
Securities requested to be so registered), unless the Holders of a majority of the Registrable Securities agree to forfeit their right to a demand registration pursuant to Section 2.1; provided, however, in the event that a
withdrawal by the Holders is based upon material adverse information relating to the Company that is different from the information known or available (upon request from the Company or otherwise) to the Holders requesting registration at the time of
their request for registration under Section 2.1, such registration shall not be treated as a counted registration for purposes of Section 2.1, even though the Holders do not bear the Registration Expenses for such registration. All
Selling Expenses relating to securities registered on behalf of the Holders shall be borne by the holders of securities included in such registration pro rata among each other on the basis of the number of Registrable Securities so
registered. 

  
 -8- 

2.5         Registration Procedures. In the case of each
registration effected by the Company pursuant to Section 2, the Company will keep each Holder advised in writing as to the initiation of each registration and as to the completion thereof At its expense, the Company will use its commercially
reasonable efforts to: 
 (a)        Keep such registration effective for a period
of time ending on the earlier of the date which is sixty (60) days from the effective date of the registration statement or such time as the Holder or Holders have completed the distribution described in the registration statement relating
thereto; provided, however, that such sixty (60) day period shall be extended for a period of time equal to the period the Holder refrains, at the request of an underwriter of Common Stock (or other securities) of the Company, from selling any
securities included in such registration; 
 (b)        Prepare and file with the
Commission such amendments and supplements to such registration statement and the prospectus used in connection with such registration statement as may be necessary to comply with the provisions of the Securities Act with respect to the disposition
of all securities covered by such registration statement for the period set forth in subsection (a) above; 

(c)        Furnish such number of prospectuses, including any preliminary
prospectuses, and other documents incident thereto, including any amendment of or supplement to the prospectus, as a Holder from time to time may reasonably request; 

(d)        Use its reasonable best efforts to register and qualify the securities
covered by such registration statement under such other securities or Blue Sky laws of such jurisdiction as shall be reasonably requested by the Holders; provided, that the Company shall not be required in connection therewith or as a
condition thereto to qualify to do business or to file a general consent to service of process in any such states or jurisdictions; 

(e)        Notify each seller of Registrable Securities covered by such registration
statement at any time when a prospectus relating thereto is required to be delivered under the Securities Act of the happening of any event as a result of which the prospectus included in such registration statement, as then in effect, includes an
untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading or incomplete in light of the circumstances then existing, and following such notification
promptly prepare and furnish to such seller a reasonable number of copies of a supplement to or an amendment of such prospectus as may be necessary so that, as thereafter delivered to the purchasers of such shares, such prospectus shall not include
an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading or incomplete in light of the circumstances then existing; 

(f)        Provide a transfer agent and registrar for all Registrable Securities
registered pursuant to such registration statement and a CUSIP number for all such Registrable Securities, in each case not later than the effective date of such registration; 

(g)        Cause all such Registrable Securities registered pursuant hereunder to be
listed on each securities exchange on which similar securities issued by the Company are then listed; and 

  
 -9- 

 (h)        In connection with any
underwritten offering pursuant to a registration statement filed pursuant to Section 2.1, enter into an underwriting agreement in form reasonably necessary to effect the offer and sale of Common Stock, provided that such underwriting
agreement contains reasonable and customary provisions, and provided further, that each Holder participating in such underwriting shall also enter into and perform its obligations under such an agreement. 

2.6         Indemnification. 

(a)        To the extent permitted by law, the Company will indemnify and hold
harmless each Holder, each of its officers, directors, members and partners, legal counsel, accountants and investment advisors and each person controlling such Holder within the meaning of Section 15 of the Securities Act, with respect to
which registration, qualification or compliance has been effected pursuant to this Section 2, and each underwriter, if any, and each person who controls within the meaning of Section 15 of the Securities Act any underwriter, against all
expenses, claims, losses, damages and liabilities (or actions, proceedings or settlements in respect thereof) arising out of or based on: (i) any untrue statement (or alleged untrue statement) of a material fact contained or incorporated by
reference in any prospectus, offering circular, or other document (including any related registration statement, notification or the like) incident to any such registration, qualification or compliance, (ii) any omission (or alleged omission)
to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, or (iii) any violation (or alleged violation) by the Company of the Securities Act, any state securities laws or any rule
or regulation thereunder applicable to the Company and relating to action or inaction required of the Company in connection with any offering covered by such registration, qualification or compliance, and the Company will reimburse each such Holder,
each of its officers, directors, members, partners, legal counsel, accountants and investment advisors and each person controlling such Holder, each such underwriter and each person who controls any such underwriter, for any legal and any other
expenses reasonably incurred in connection with investigating and defending or settling any such claim, loss, damage, liability or action; provided that the Company will not be liable in any such case to the extent that any such claim, loss,
damage, liability, or action arises out of or is based on any untrue statement or omission based upon written information furnished to the Company by such Holder, any of such Holder’s officers, directors, members, partners, legal counsel,
accountants or investment advisors, any person controlling such Holder, such underwriter or any person who controls any such underwriter, and stated to be specifically for use therein; and provided, further that, the indemnity agreement
contained in this Section 2.6(a) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Company (which consent shall not be unreasonably
withheld). 
 (b)        To the extent permitted by law, each Holder (severally and
not jointly) will, if Registrable Securities held by such Holder are included in the securities as to which such registration, qualification or compliance is being effected, indemnify and hold harmless the Company, each of its directors, officers,
partners, legal counsel and accountants and each underwriter, if any, of the Company’s securities covered by such a registration statement, each person who controls the Company or such underwriter within the meaning of Section 15 of the
Securities Act, each other such Holder, and each of their officers, directors, members and partners, and each person controlling each other such Holder, against all claims, losses, damages and liabilities (or actions in respect thereof) arising out
of or based on: (i) any untrue statement (or alleged untrue statement) of a material fact contained 

  
 -10- 

 
or incorporated by reference in any prospectus, offering circular or other document (including any related registration statement, notification, or the like) incident to any such registration,
qualification or compliance, or (ii) any omission (or alleged omission) to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, and will reimburse the Company and such Holders,
officers, directors, members, partners, legal counsel and accountants, persons, underwriters, or control persons for any legal or any other expenses reasonably incurred in connection with investigating or defending any such claim, loss, damage,
liability or action, in each case to the extent, but only to the extent, that such untrue statement (or alleged untrue statement) or omission (or alleged omission) is made in such registration statement, prospectus, offering circular or other
document in reliance upon and in conformity with written information furnished to the Company by such Holder and stated to be specifically for use therein; provided, however, that the obligations of such Holder hereunder shall not apply to
amounts paid in settlement of any such claims, losses, damages or liabilities (or actions in respect thereof) if such settlement is effected without the consent of such Holder (which consent shall not be unreasonably withheld); and provided
that in no event shall any indemnity under this Section 2.6 exceed the net proceeds from the offering received by such Holder, except in the case of fraud or willful misconduct by such Holder. 

(c)        Each party entitled to indemnification under this Section 2.6 (the
“Indemnified Party”) shall give notice to the party required to provide indemnification (the “Indemnifying Party”) promptly after such Indemnified Party has actual knowledge of any claim as to which
indemnity may be sought, and shall permit the Indemnifying Party to assume the defense of such claim or any litigation resulting therefrom; provided that counsel for the Indemnifying Party, who shall conduct the defense of such claim or any
litigation resulting therefrom, shall be approved by the Indemnified Party (whose approval shall not be unreasonably withheld), and the Indemnified Party may participate in such defense at such party’s expense; and provided further that
the failure of any Indemnified Party to give notice as provided herein shall not relieve the Indemnifying Party of its obligations under this Section 2.6, to the extent such failure is not prejudicial. No Indemnifying Party, in the defense of
any such claim or litigation, shall, except with the consent of each Indemnified Party, consent to entry of any judgment or enter into any settlement that does not include as an unconditional term thereof the giving by the claimant or plaintiff to
such Indemnified Party of a release from all liability in respect to such claim or litigation. Each Indemnified Party shall furnish such information regarding itself or the claim in question as an Indemnifying Party may reasonably request in writing
and as shall be reasonably required in connection with defense of such claim and litigation resulting therefrom. 

(d)        If the indemnification provided for in this Section 2.6 is held by a
court of competent jurisdiction to be unavailable to an Indemnified Party with respect to any loss, liability, claim, damage, or expense referred to herein, then the Indemnifying Party, in lieu of indemnifying such Indemnified Party hereunder, shall
contribute to the amount paid or payable by such Indemnified Party as a result of such loss, liability, claim, damage, or expense in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party on the one hand and of the
Indemnified Party on the other in connection with the statements or omissions that resulted in such loss, liability, claim, damage, or expense as well as any other relevant equitable considerations. The relative fault of the Indemnifying Party and
of the Indemnified Party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission to state a material fact relates to information supplied by the Indemnifying Party or
by the Indemnified Party and the parties’ relative intent, knowledge, access to information, and opportunity to correct or prevent 

  
 -11- 

 
such statement or omission. No Holder will be required under this Section 2.6(d) to contribute any amount in excess of the difference between (i) the net proceeds from the offering
received by such Holder and (ii) any amounts paid or payable by such Holder pursuant to Section 2.6(b), except in the case of fraud or willful misconduct by such Holder. No person or entity guilty of fraudulent misrepresentation (within
the meaning of Section 11(f) of the Securities Act) will be entitled to contribution from any person or entity who was not guilty of such fraudulent misrepresentation. 

(e)        Notwithstanding the foregoing, to the extent that the provisions on
indemnification and contribution contained in the underwriting agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting agreement shall control. 

2.7         Information by Holder. Each Holder of Registrable
Securities shall furnish to the Company such information regarding such Holder and the distribution proposed by such Holder as the Company may reasonably request in writing and as shall be reasonably required in connection with any registration,
qualification, or compliance referred to in this Section 2. 

2.8         Restrictions on Transfer. 

(a)        The holder of each certificate representing Registrable Securities by
acceptance thereof agrees to comply in all respects with the provisions of this Section 2.8. Each Holder agrees not to make any sale, assignment, transfer, pledge or other disposition of all or any portion of the Restricted Securities, or any
beneficial interest therein, unless and until the transferee thereof has agreed in writing for the benefit of the Company to take and hold such Restricted Securities subject to, and to be bound by, the terms and conditions set forth in this
Agreement, including, without limitation, this Section 2.8 and Section 2.10, and: 

(i)        there is then in effect a registration statement under the Securities Act
covering such proposed disposition and such disposition is made in accordance with such registration statement; or 

(ii)        such Holder shall have given prior written notice to the Company of the
Holder’s intention to make such disposition and shall have furnished the Company with a detailed description of the manner and circumstances of the proposed disposition, and, if requested by the Company, such Holder shall have furnished the
Company, at the Holder’s expense, with (A) an opinion of counsel, reasonably satisfactory to the Company, to the effect that such disposition will not require registration of such Restricted Securities under the Securities Act or
(B) a “no action” letter from the Commission to the effect that the transfer of such securities without registration will not result in a recommendation by the staff of the Commission that action be taken with respect thereto,
whereupon the holder of such Restricted Securities shall be entitled to transfer such Restricted Securities in accordance with the terms of the notice delivered by the Holder to the Company. It is agreed that the Company will not require opinions of
counsel for transactions made pursuant to Rule 144 except in unusual circumstances. 

(b)        Notwithstanding the provisions of Section 2.8(a), no such
registration statement, opinion of counsel or “no action” letter shall be necessary for (i) a transfer not involving a 

  
 -12- 

 
change in beneficial ownership, or (ii) transactions involving the distribution of Restricted Securities by any Holder to (x) a parent, subsidiary or other affiliate of the Holder, if
the Holder is an entity, (y) any of the Holder’s partners, members or other equity owners, or retired partners, retired members or other equity owners, or to the estate of any of the Holder’s partners, members or other equity owners
or retired partners, retired members or other equity owners, or (z) a venture capital or other investment fund that is controlled by or under common control with one or more general partners or managing members of, or shares the same management
company or investment advisor with, the Holder; provided, in each case, that the Holder thereof shall give written notice to the Company of such Holder’s intention to effect such disposition and shall have furnished the Company with a detailed
description of the manner and circumstances of the proposed disposition. 

(c)        Each certificate representing Registrable Securities shall (unless
otherwise permitted by the provisions of this Agreement) be stamped or otherwise imprinted with a legend substantially similar to the following (in addition to any legend required under applicable state securities laws): 

THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATE. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS PURSUANT TO
REGISTRATION OR AN EXEMPTION THEREFROM. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE ISSUER THAT SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION OTHERWISE COMPLIES WITH THE ACT AND ANY
APPLICABLE STATE SECURITIES LAWS. 
 THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON
TRANSFERABILITY AND RESALE, INCLUDING A LOCK-UP PERIOD IN THE EVENT OF A PUBLIC OFFERING, AS SET FORTH IN AN AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT BY AND AMONG THE COMPANY AND THE ORIGINAL
HOLDERS OF THESE SHARES, A COPY OF WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICE OF THE COMPANY. 
 The Holders consent to the Company
making a notation on its records and giving instructions to any transfer agent of the Restricted Securities in order to implement the restrictions on transfer established in this Section 2.8. 

(d)        The first legend referring to federal and state securities laws identified
in Section 2.8(c) stamped on a certificate evidencing the Restricted Securities and the stock transfer instructions and record notations with respect to such Restricted Securities shall be removed and the Company shall issue a certificate
without such legend to the holder of such Restricted Securities if (i) such securities are registered under the Securities Act, or (ii) such holder provides the Company with 

  
 -13- 

 
an opinion of counsel reasonably acceptable to the Company to the effect that a sale or transfer of such securities may be made without registration or qualification. 

2.9         Rule 144 Reporting. With a view to making available the
benefits of certain rules and regulations of the Commission that may permit the sale of the Restricted Securities to the public without registration, the Company agrees to use its commercially reasonable efforts to: 

(a)        Make and keep adequate current public information with respect to the
Company available in accordance with Rule 144 under the Securities Act, at all times from and after the effective date of the Company’s Initial Public Offering; 

(b)        File with the Commission in a timely manner all reports and other
documents required of the Company under the Securities Act and the Exchange Act at any time after it has become subject to such reporting requirements; and 

(c)        So long as a Holder owns any Restricted Securities, furnish to the Holder
forthwith upon written request a written statement by the Company as to its compliance with the reporting requirements of Rule 144 (at any time from and after ninety (90) days following the effective date of the first registration statement
filed by the Company for an offering of its securities to the general public), and of the Securities Act and the Exchange Act (at any time after it has become subject to such reporting requirements), a copy of the most recent annual or quarterly
report of the Company, and such other reports and documents so filed as a Holder may reasonably request in availing itself of any rule or regulation of the Commission allowing a Holder to sell any such securities without registration. 

2.10        Market Stand-Off
Agreement. Each Holder and transferee thereof hereby agrees that such Holder or transferee shall not, without the prior written consent of the managing underwriter, sell or otherwise transfer, make any short sale of, grant any option for the
purchase of, or enter into any hedging or similar transaction with the same economic effect as a sale, of any Common Stock (or other securities) of the Company held by such Holder or transferee (other than those included in the registration, Common
Stock acquired in the Initial Public Offering and Common Stock acquired in open market transactions on or after the consummation of the Initial Public Offering) during the one hundred and eighty (180) day period following the effective date of
the registration statement for the Company’s Initial Public Offering, provided that all officers and directors of the Company and all holders of more than one percent (1%) of the Company’s voting securities are bound by and have
entered into similar agreements. The obligations described in this Section 2.10 shall apply only to the Initial Public Offering. The Company may impose stop-transfer instructions and may stamp each such certificate with the second legend set
forth in Section 2.8(c) with respect to the shares of Common Stock (or other securities) subject to the foregoing restriction until the end of such one hundred and eighty (180) day (or other) period. If any of the obligations described in
this Section 2.10 are waived or terminated with respect to any of the securities of any such Holder, officer, director or greater than one percent stockholder (in any such case, the “Released Securities”), the foregoing
provisions shall be waived or terminated, as applicable, to the same extent and with respect to the same percentage of securities of each Investor as the percentage of Released Securities represent with respect to the securities held by the
applicable Holder, officer, director or greater than one percent stockholder subject to customary exceptions as agreed upon with said underwriters. Each Holder agrees to execute 

  
 -14- 

 
a market standoff agreement with said underwriters in customary form consistent with the provisions of this Section 2.10. 

2.11        Delay of Registration. No Holder shall have any right to
take any action to restrain, enjoin, or otherwise delay any registration as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 2. 

2.12        Intentionally Omitted. 

2.13        Limitations on Subsequent Registration Rights. From and
after the date of this Agreement, the Company shall not, without the prior written consent of the Requisite Holders (excluding any shares held by any Holders whose rights to request registration or inclusion in any registration pursuant to this
Section 2 have terminated in accordance with Section 2.14), enter into any agreement with any holder or prospective holder of any securities of the Company giving such holder or prospective holder any registration rights the terms of which
are senior to or on parity with the registration rights granted to the Holders hereunder. 

2.14        Termination of Registration Rights. The right of any Holder
to request registration or inclusion in any registration pursuant to Sections 2.1, 2.2 or 2.3 shall terminate on the earlier of (i) such date, on or after the closing of the Company’s Initial Public Offering, on which all shares of
Registrable Securities held or entitled to be held upon conversion by such Holder may immediately be sold under Rule 144 during any ninety (90) day period, (ii) four (4) years after the closing of the Company’s Initial Public
Offering, and (iii) immediately prior to the closing of a Deemed Liquidation Event (as defined in the Restated Certificate). 

Section 3 
 INFORMATION
COVENANTS OF THE COMPANY 
 The Company hereby covenants and agrees, as follows: 

3.1         Basic Financial Information and Inspection Rights. 

(a)        Basic Financial Information. The Company will furnish the
following reports to each Holder who, together with its Affiliates, (i) owns an aggregate of at least 1,000,000 Shares and/or shares of Common Stock issued upon conversion of Shares (as presently constituted and subject to subsequent
adjustments for stock splits, stock dividends, reverse stock splits, and the like) or (ii) in the case of each of GBG-1 Corporation and Dong-A Socio Holdings, such
number of Shares which, when taken together with any Shares which are already owned by it and any Shares already owned by the other of them equates to an aggregate of at least 1,000,000 Shares (as presently constituted and subject to subsequent
adjustments for stock splits, stock dividends, reverse stock splits, and the like) (each a “Major Investor”): 

(i)        As soon as practicable after the end of each fiscal year of the Company,
and in any event within one hundred and eighty (180) days after the end of each fiscal year of the Company, a consolidated balance sheet of the Company and its subsidiaries, if any, as at the end of such fiscal year, and consolidated statements
of income and cash flows of the Company and its 

  
 -15- 

 
subsidiaries, if any, for such year, prepared in accordance with U.S. generally accepted accounting principles consistently applied; 

(ii)        As soon as practicable after the end of the first, second and third
quarterly accounting periods in each fiscal year of the Company, and in any event within forty five (45) days after the end of the first, second, and third quarterly accounting periods in each fiscal year of the Company, an unaudited
consolidated balance sheet of the Company and its subsidiaries, if any, as of the end of each such quarterly period, and unaudited consolidated statements of income and cash flows of the Company and its subsidiaries, if any, for such period,
prepared in accordance with U.S. generally accepted accounting principles consistently applied, subject to changes resulting from normal year-end audit adjustments; 

(iii)        Upon request, as soon as practicable after the end of each month, and in
any event within thirty (30) days after the end of each month, an unaudited consolidated balance sheet of the Company and its subsidiaries, if any, as of the end of such monthly period, and unaudited consolidated statements of income and cash
flows of the Company and its subsidiaries, if any, for such period, prepared in accordance with U.S. generally accepted accounting principles consistently applied, subject to changes resulting from normal
year-end audit adjustments; and 

(iv)        Upon request, the capitalization table of the Company. 

(b)        Inspection Rights. The Company will afford to each Major
Investor and its accountants and counsel, reasonable access during normal business hours to all of the Company’s respective properties, books and records. Each Major Investor shall have such other access to management and information as is
necessary for it to comply with applicable laws and regulations and reporting obligations. The Company shall not be required to disclose details of contracts with or work performed for specific customers and other business partners where to do so
would violate confidentiality obligations to those parties. Major Investors may exercise their rights under this Section 3.1(b) only for purposes reasonably related to their interests under this Agreement and related agreements. The rights
granted pursuant to this Section 3.1(b) may not be assigned or otherwise conveyed by the Major Investors or by any subsequent transferee of any such rights without the prior written consent of the Company except as authorized in this
Section 3.1(b). 
 3.2         Confidentiality. Each Holder
acknowledges that the information received by it pursuant to Section 3 of this Agreement may be confidential and, to the extent such information is confidential information of the Company, such Holder shall not disclose such information to
individuals or entities (other than individuals or entities affiliated with such Holder with a need to know such confidential information, and its attorneys and accountants), except that such Holder may disclose such confidential information
(i) to any Affiliate, partner, member, or stockholder or investment advisors of such Holder in the ordinary course of business, provided that such Holder informs such person that such information is confidential and directs such person to
maintain the confidentiality of such information; (ii) at such time as it enters the public domain through no fault of such Holder; (iii) that is communicated to it by a third party free of any obligation of confidentiality; (iv) that
is developed by Holder or its agents independently of and without reference to any such confidential information; or (vi) as required by applicable law. 

  
 -16- 

 3.3        Confidential
Information and Invention Assignment Agreements. The Company shall require all new employees to execute and deliver the Company’s standard form of Confidential Information and Invention Assignment Agreement and all new consultants and
advisors to execute and deliver appropriate confidential information and invention assignment agreements with the Company. 

3.4        Stock Option Vesting. Except as may be approved by the Board
of Directors, all stock options, restricted stock and similar equity grants issued after the date of this Agreement by the Company to employees, officers and consultants shall be subject to vesting as follows: (i) twenty-five percent (25%) of
such stock shall vest on the one (1) year anniversary of such person’s service commencement date with the Company and (ii) the remaining seventy-five percent (75%) of such stock shall vest monthly over the remaining thirty-six (36) months. The Company shall retain a repurchase option with respect to any unvested shares of restricted stock and similar equity grants of the Company (to the extent exercised), pursuant to which
the Company (or its assignee, subject to compliance with applicable federal and state securities laws) shall be entitled to repurchase such shares of restricted stock upon the termination of employment or the provision of services of such
stockholder, with or without cause, at a purchase price per share no greater than the original purchase price paid by such stockholder for such shares. No stock option, restricted stock or similar equity grant issued to officers or consultants shall
be transferable until such time as such stock option, restricted stock or similar equity grant is fully vested. 

3.5        Right of First Refusal. Each future holder of the
Company’s Common Stock (other than Common Stock issued upon conversion of the Shares) shall be bound by a right of first refusal or right of first offer in favor of the Company. To the extent that the Company elects not to exercise any right of
first refusal or right of first offer the Company may have on a proposed transfer of any of the Company’s Common Stock pursuant to the Company’s charter documents, by contract or otherwise, the Company shall, to the extent it may do so and
to the extent such holders do not already have such rights, assign such right of first refusal or right of first offer to the holders of the Preferred Stock. In the event of such assignment, each holder of Preferred Stock shall have a right to
purchase its pro rata share of the shares of Common Stock proposed to be transferred. Each holder’s pro rata share shall be a number of shares equal to the product of (i) the aggregate number of shares of Common Stock proposed to be
transferred multiplied by (ii) a fraction, the numerator of which is the number of shares of Preferred Stock held by such holder at the time of the proposed transfer and the denominator of which is the total number of shares of Preferred Stock
held by all holders of Preferred Stock at the time of such proposed transfer. Each holder of Preferred Stock shall have a right of overallotment such that if any holder of Preferred Stock fails to exercise its right hereunder to purchase its full
pro rata share of any shares of Common Stock proposed to be transferred pursuant to this Section 3.5, the fully-participating holders of Preferred Stock may purchase such remaining shares of Common Stock on a pro rata basis. 

3.6        Indemnification Agreements. The Company shall enter into
indemnification agreements with all of its directors in a form reasonably acceptable to all then-serving Preferred Directors (as defined in the Company’s certificate of incorporation). 

3.7        Directors and Officers Insurance. To the extent that coverage
is available upon commercially reasonable terms, as determined by the Board of Directors, the Company shall maintain 

  
 -17- 

 
directors and officers liability insurance with coverage limits customary for similarly situated companies on terms and conditions reasonably acceptable to the Board of Directors, including all
of the then-serving Preferred Directors. 
 3.8         Termination
of Covenants. 
 (a)        The covenants set forth in this Section 3
shall terminate and be of no further force and effect upon the earlier of (i) immediately prior to the closing of the Company’s Initial Public Offering and (ii) immediately prior to the closing of a Deemed Liquidation Event (as
defined in the Restated Certificate), provided, however, that Section 3.1(a) shall survive a Deemed Liquidation Event pursuant to which the consideration distributed to the Major Investors includes securities of a company that is not subject to
the periodic reporting requirements of Sections 12 or 15(d) of the Exchange Act. 

(b)        The covenants set forth in Section 3.1 shall terminate as to each
Holder and be of no further force or effect when the Company first becomes subject to the periodic reporting requirements of Sections 12 of 15(d) of the Exchange Act, if earlier than the events described in Section 3.8(a). 

Section 4 
 RIGHT OF FIRST
REFUSAL 
 4.1         Right of First Refusal to Major
Investors. 
 (a)        The Company hereby grants to each Major Investor the
right of first refusal to purchase up to its pro rata share of New Securities (as defined in Section 4.1(b)) which the Company may, from time to time, propose to sell and issue after the date of this Agreement. For the avoidance of
doubt, each Major Investor shall have the right to apportion its Pro Rata Share (as defined below) among its affiliated entities. A Major Investor’s pro rata share, for purposes of this right of first refusal, is equal to the ratio of
(i) the number of shares of Common Stock owned by such Major Investor immediately prior to the issuance of New Securities (assuming full conversion of the Preferred Stock then held by such Major Investor and full conversion or exercise of all
outstanding convertible securities, rights, options and warrants held by such Major Investor) to (ii) the total number of shares of Common Stock outstanding immediately prior to the issuance of such New Securities (assuming full conversion of
the Shares and full conversion or exercise of all outstanding convertible securities, rights, options and warrants) (such amount, a “Pro Rata Share”). Each Major Investor shall have a right of overallotment such that if any
Major Investor fails to exercise its right hereunder to purchase its full Pro Rata Share of any New Securities, the fully-participating Major Investors may purchase such remaining New Securities on a pro rata basis. 

(b)        “New Securities” shall mean any capital stock
(including Common Stock and/or Preferred Stock) of the Company whether now authorized or not, and rights, convertible securities, options or warrants to purchase such capital stock, and securities of any type whatsoever that are, or may become,
exercisable or convertible into capital stock; provided that the term “New Securities” does not include: (i) securities or rights to acquire securities that are excluded from the

  
 -18- 

 
definition of Additional Shares of Common in the Restated Certificate and (ii) shares of Series D Preferred Stock issued pursuant to the Purchase Agreement. 

(c)        In the event the Company proposes to undertake an issuance of New
Securities, it shall give each Major Investor written notice of its intention, describing the type of New Securities, and their price and the general terms upon which the Company proposes to issue the same. Each Major Investor shall have fifteen
(15) business days after any such notice is mailed or delivered to agree to purchase all or a portion of such Holder’s Pro Rata Share of such New Securities and any overallotment amount for the price and upon the terms specified in the
notice by giving written notice to the Company stating therein the quantity of New Securities to be purchased. 

(d)        In the event the Major Investors fail to exercise fully the right of first
refusal within said fifteen (15) business day period (the “Election Period”), the Company shall have ninety (90) days thereafter to sell or enter into an agreement (pursuant to which the sale of New Securities
covered thereby shall be closed, if at all, within ninety (90) days from the date of said agreement) to sell that portion of the New Securities with respect to which the Major Investors’ right of first refusal option set forth in this
Section 4.1 was not exercised, at a price and upon terms no more favorable to the purchasers thereof than specified in the Company’s notice to Major Investors delivered pursuant to Section 4.1(c). In the event the Company has not sold
within such ninety (90) day period following the Election Period, or such ninety (90) day period following the date of said agreement, the Company shall not thereafter issue or sell any New Securities, without first again offering such
securities to the Major Investors in the manner provided in this Section 4.1. 

(e)        The right of first refusal granted under this Agreement shall expire upon
the earlier of (i) immediately prior to the closing of the Company’s Initial Public Offering and (ii) immediately prior to the closing of a Deemed Liquidation Event (as defined in the Restated Certificate). 

(f)        Notwithstanding the foregoing, the right of first refusal granted under
this Agreement shall not be applicable with respect to any Major Holder if, (i) at the time of the proposed sale and issuance of New Securities, such Major Holder is not an “accredited investor” as defined in Section 501 of
Regulation D of the Exchange Act and (ii) such sale and issuance of New Securities is otherwise only being offered to accredited investors. 

(g)        In the event that the right of first offer in this Section 4.1 is
waived in accordance with Section 5.1, and any Major Investor that consented to such waiver (a “Waiving Major Investor”) nevertheless purchases New Securities subject to such waiver, each Major Investor that is not a
Waiving Major Investor and that otherwise has not been offered an opportunity to purchase its Pro Rata Share of the issuance of New Securities shall be entitled to purchase its Adjusted Pro Rata Share (as defined below) of such New Securities upon
the terms and conditions set forth in this Section 4. For purposes of this Section 4.1(g), a Major Investor’s “Adjusted Pro Rata Share” of the New Securities subject to the waiver described herein shall be equal to
(i) such Major Investor’s Pro Rata Share of such New Securities multiplied by (ii) the highest percentage (up to 100%) of any Waiving Major Investor’s Pro Rata Share that such Waiving Major Investor purchased. For example, if
only one Waiving Major Investor is permitted to purchase any New Securities and purchases 50% of its 

  
 -19- 

 
Pro Rata Share of the New Securities, each Major Investor’s Adjusted Pro Rata Share shall be 50% of its Pro Rata Share. 

Section 5 
 MISCELLANEOUS

 5.1        Amendment. Except as expressly provided herein,
neither this Agreement nor any term hereof may be amended, waived, discharged or terminated other than by a written instrument referencing this Agreement and signed by the Company and the Requisite Holders (excluding any shares held by Holders that
have been sold to the public or pursuant to Rule 144, and excluding, with respect to Section 2 (other than Sections 2.8, 2.9 and 2.10), any of such shares held by any Holders whose rights to request registration or inclusion in any registration
pursuant to Section 2 have terminated in accordance with Section 2.14); provided, however, that Holders purchasing Shares in a Subsequent Closing (as defined in the Purchase Agreement) may become parties to this Agreement by
executing a counterpart of this Agreement without any amendment of this Agreement pursuant to this paragraph or any consent or approval of any other Holder; and provided, further, that if any amendment, waiver, discharge or termination operates in a
manner that treats any Holder or class of Holders different from other Holders, the consent of such Holder or class of Holders shall also be required for such amendment, waiver, discharge or termination. Notwithstanding the foregoing, the amendment,
waiver, discharge or termination of Section 3.1 and Section 4 of this Agreement shall require the written consent of the Company and the Major Investors holding a majority of the Registrable Securities then held by all Major Investors
(excluding any of such shares that have been sold to the public or pursuant to Rule 144, and excluding, with respect to Section 2 (other than Sections 2.8, 2.9 and 2.10), any of such shares held by any Holders whose rights to request
registration or inclusion in any registration pursuant to Section 2 have terminated in accordance with Section 2.14). Any such amendment, waiver, discharge or termination effected in accordance with this paragraph shall be binding upon
each Holder and each future holder of all such securities of Holder. Each Holder acknowledges that by the operation of this paragraph, the Requisite Holders (excluding any shares held by Holders that have been sold to the public or pursuant to Rule
144, and excluding, with respect to Section 2 (other than Sections 2.8, 2.9 and 2.10), any of such shares held by any Holders whose rights to request registration or inclusion in any registration pursuant to Section 2 have terminated in
accordance with Section 2.14) will have the right and power to diminish or eliminate all rights of such Holder under this Agreement, subject to any specific consent rights set forth herein. 

5.2        Notices.  All notices and other communications
required or permitted hereunder shall be in writing and shall be mailed by registered or certified mail, postage prepaid, sent by facsimile or electronic mail (if to an Investor or Holder) or otherwise delivered by hand, messenger or courier service
addressed: 
 (a)        if to an Investor, to the Investor’s address,
facsimile number or electronic mail address as shown in the Company’s records, as may be updated in accordance with the provisions hereof; 

(b)        if to any Holder, to such address, facsimile number or electronic mail
address or facsimile number as shown in the Company’s records, or, until any such Holder so furnishes an 

  
 -20- 

 
address, facsimile number or electronic mail address to the Company, then to the address, facsimile number or electronic mail address of the last holder of such shares for which the Company has
contact information in its records; or 
 (c)        if to the Company, to the
attention of the President and Chief Executive Officer of the Company, 240 East Grand Avenue, 2nd Floor, South San Francisco, CA 94080, or at such other current address as the Company shall have furnished to the Investors or Holders, with a copy
(which shall not constitute notice) to Ken Clark, Wilson Sonsini Goodrich & Rosati, P.C., 650 Page Mill Road, Palo Alto, CA 94304. 

Each such notice or other communication shall for all purposes of this Agreement be treated as effective or having been given
(i) if delivered by hand, messenger or courier service, when delivered (or if sent via a nationally-recognized overnight courier service, freight prepaid, specifying next-business-day delivery, one
business day after deposit with the courier), or (ii) if sent via mail, at the earlier of its receipt or five days after the same has been deposited in a regularly-maintained receptacle for the deposit of the United States mail, addressed and
mailed as aforesaid, or (iii) if sent via facsimile, upon confirmation of facsimile transfer or, if sent via electronic mail, upon confirmation of delivery when directed to the relevant electronic mail address, if sent during normal business
hours of the recipient, or if not sent during normal business hours of the recipient, then on the recipient’s next business day. In the event of any conflict between the Company’s books and records and this Agreement or any notice
delivered hereunder, the Company’s books and records will control absent fraud or error. 
 Subject to the limitations
set forth in Delaware General Corporation Law §232(e), each Investor and Holder consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s certificate of
incorporation or bylaws by (i) facsimile telecommunication to the facsimile number set forth on Exhibit A (or to any other facsimile number for the Investor or Holder in the Company’s records) or (ii) electronic mail to the electronic
mail address set forth on Exhibit A (or to any other electronic mail address for the Investor or Holder in the Company’s records). This consent may be revoked by an Investor or Holder by written notice to the Company and may be deemed revoked
in the circumstances specified in Delaware General Corporation Law §232. 

5.3        Governing Law. This Agreement shall be governed in all
respects by the internal laws of the State of Delaware as applied to agreements entered into among Delaware residents to be performed entirely within Delaware, without regard to principles of conflicts of law. 

5.4        Successors and Assigns. The rights under this Agreement may
be assigned (but only with all related obligations) by a Holder to a transferee of Registrable Securities that is (a) a transferee or assignee of at least 250,000 shares of Registrable Securities (as presently constituted and subject to
subsequent adjustments for stock splits, stock dividends, reverse stock splits, and the like) (or all shares of Registrable Securities held by the transferring Holder, if less than such number) or (b) any of the Holder’s Affiliates,
partners, members or other equity owners, or retired partners, retired members or other equity owners, or, if the Holder is a venture capital or other investment fund, then to an entity that is controlled by or under common control with one or more
general partners or managing members of, or shares the same management company or investment advisor with, the Holder; provided that (i) 

  
 -21- 

 
such transfer or assignment of Registrable Securities is effected in accordance with the terms of Section 2.8, the Right of First Refusal and Co-Sale
Agreement and applicable securities laws, (ii) the Company is given written notice prior to said transfer or assignment, stating the name and address of the transferee or assignee and identifying the securities with respect to which such rights
are intended to be transferred or assigned and (iii) the transferee or assignee of such rights assumes in writing the obligations of such Holder under this Agreement, including without limitation the obligations set forth in Section 2.10.
Any attempt by a Holder to assign, transfer, delegate or sublicense any rights, duties or obligations that arise under this Agreement not in compliance with the foregoing sentence shall be void. Subject to the foregoing and except as otherwise
provided herein, the provisions of this Agreement shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators of the parties hereto. 

5.5        Entire Agreement.  This Agreement and the exhibits
hereto constitute the full and entire understanding and agreement between the parties with regard to the subjects hereof No party hereto shall be liable or bound to any other party in any manner with regard to the subjects hereof or thereof by any
warranties, representations or covenants except as specifically set forth herein. 

5.6        Delays or Omissions.  Except as expressly provided
herein, no delay or omission to exercise any right, power or remedy accruing to any party to this Agreement upon any breach or default of any other party under this Agreement shall impair any such right, power or remedy of such non-defaulting party, nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring, nor shall any waiver of any
single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement,
or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or
otherwise afforded to any party to this Agreement, shall be cumulative and not alternative. 

5.7        Severability.  If any provision of this Agreement
becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, portions of such provision, or such provision in its entirety, to the extent necessary, shall be severed from this Agreement, and such court will
replace such illegal, void or unenforceable provision of this Agreement with a valid and enforceable provision that will achieve, to the extent possible, the same economic, business and other purposes of the illegal, void or unenforceable provision.
The balance of this Agreement shall be enforceable in accordance with its terms. 

5.8        Titles and Subtitles.  The titles and subtitles
used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement. All references in this Agreement to sections, paragraphs and exhibits shall, unless otherwise provided, refer to sections
and paragraphs hereof and exhibits attached hereto. 

5.9        Counterparts.  This Agreement may be executed in
any number of counterparts, each of which shall be enforceable against the parties that execute such counterparts, and all of which together shall constitute one instrument. 

  
 -22- 

 5.10        Telecopy
Execution and Delivery. A facsimile, telecopy or other reproduction of this Agreement may be executed by one or more parties hereto and delivered by such party by facsimile or any similar electronic transmission device pursuant to which the
signature of or on behalf of such party can be seen. Such execution and delivery shall be considered valid, binding and effective for all purposes. At the request of any party hereto, all parties hereto agree to execute and deliver an original of
this Agreement as well as any facsimile, telecopy or other reproduction hereof 

5.11        Jurisdiction; Venue.    With respect to
any disputes arising out of or related to this Agreement, each of the parties hereto irrevocably consents to the exclusive jurisdiction of, and venue in, the courts of the State of Delaware and the United States District Court for the District of
Delaware. 
 5.12        Further
Assurances.    Each party hereto agrees to execute and deliver, by the proper exercise of its corporate, limited liability company, partnership or other powers, all such other and additional instruments and documents and do
all such other acts and things as may be necessary to more fully effectuate this Agreement. 

5.13        Conflict.    In the event of any
conflict between the terms of this Agreement and the Company’s certificate of incorporation or its bylaws, the terms of the Company’s certificate of incorporation or its bylaws, as the case may be, will control. 

5.14        Attorney’s
Fees.    In the event that any suit or action is instituted to enforce any provisions in this Agreement, the prevailing party in such dispute shall be entitled to recover from the losing party all fees, costs and expenses of
enforcing any right of such prevailing party under or with respect to this Agreement, including without limitation, such reasonable fees and expenses of attorneys and accountants, which shall include, without limitation, all fees, costs and expenses
of appeals. 
 5.15        Aggregation of
Stock.    All securities held or acquired by Affiliates shall be aggregated together for purposes of determining the availability of any rights under this Agreement. 

5.16        Amendment of Prior Rights
Agreement.    The Prior Rights Agreement is hereby amended and superseded in its entirety and restated herein. Such amendment and restatement is effective upon execution of this Agreement by the Company and the parties
required for an amendment pursuant to Section 5.1 of the Prior Rights Agreement. Upon such execution, all provisions of, rights granted and covenants made in the Prior Rights Agreement are hereby waived, released and superseded in their
entirety by the provisions hereof and shall have no further force or effect. 
 (signature page follows) 

  
 -23- 

 The parties are signing this Amended and Restated Investors’ Rights
Agreement as of the date stated in the introductory clause. 
  

			
	 COMPANY

	
	 ORIC PHARMACEUTICALS, INC.

		
	 By:    
	 	 /s/ Jacob Chacko

	         Name:     Jacob
Chacko, MD

	         Title:
      President and Chief Executive Officer

  
 [Signature page to the Amended
and Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights
Agreement as of the date stated in the introductory clause. 
  

			
	 INVESTOR

	
	 Meridian Small Cap Growth Fund

	 By:       its Investment Adviser

ArrowMark Colorado Holdings, LLC

		
	 By:      
	 	 /s/ David Corkins

	        Name: David Corkins
	        Title: Managing Member

  
 [Signature page to the Amended
and Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights
Agreement as of the date stated in the introductory clause. 
  

			
	 INVESTOR

	
	 ArrowMark Life Science Fund, LP

	 By:   its General Partner

AMP Life Science GP, LLC

		
	 By:     
	 	/s/ David Corkins
	          Name:
      David Corkins

	          Title:
        Managing Member

  
 [Signature page to the Amended
and Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights
Agreement as of the date stated in the introductory clause. 
  

			
	 INVESTOR

	
	 ArrowMark Fundamental Opportunity Fund, L.P.

	
	 By:        its General Partner

ArrowMark Partners GP, LLC

		
	 By     
	 	 /s/ David Corkins

	      Name:        
David Corkins

	
     Title:           Managing
Member

  
 [Signature page to the Amended
and Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights
Agreement as of the date stated in the introductory clause. 
  

			
	 INVESTOR

	
	 Lookfar Investments, LLC

		
	 By:    
	 	/s/ David Corkins
	      Name:
        David Corkins

	      Title:
          Managing Member

  
 [Signature page to the Amended
and Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights
Agreement as of the date stated in the introductory clause. 
  

			
	INVESTOR
	
	CF Ascent, LLC
		
	By:	 	        /s/ David Corkins                         
               
	 Name:         David Corkins

	 Title:           Managing Member

  
 [Signature page to the Amended
and Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights
Agreement as of the date stated in the introductory clause. 
  

			
	INVESTOR
	
	THB Iron Rose, LLC
	By:       its Investment Adviser
	ArrowMark Colorado Holdings, LLC
		
	By:	 	      /s/ David Corkins                           
             
	 Name:  David Corkins

	 Title:  Managing Member

  
 [Signature page to the Amended
and Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights
Agreement as of the date stated in the introductory clause. 
  

			
	INVESTOR
	
	Iron Horse Investments, LLC
	By:  its Investment Adviser
	ArrowMark Colorado Holdings, LLC
		
	By:	 	    /s/ David Corkins                             
           
	 Name:     David Corkins

	 Title:       Managing Member

  
 [Signature page to the Amended
and Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights
Agreement as of the date stated in the introductory clause. 
  

			
	INVESTOR
	
	CITY HILL, LLC
		
	By:	 	/s/ Jonathan Lim
	Name:	 	Jonathan Lim
	Title:	 	Managing Partner and Founder

  
 [Signature page to the Amended
and Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights
Agreement as of the date stated in the introductory clause. 
  

			
	INVESTOR
	
	MEMORIAL SLOAN KETTERING CANCER CENTER.
		
	By:	 	/s/ Cason Klien
	Name:	 	Cason Klein
	Title:	 	Senior Vice President & CIO

  
 [Signature page to the Amended
and Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights
Agreement as of the date stated in the introductory clause. 
  

			
	INVESTOR
	
	ECOR1 CAPITAL FUND, L.P.
		
	By:	 	/s/ Oleg Nodelman
	Name:	 	Oleg Nodelman
	Title:  Managing Director, EcoR1 Capital, LLC

  
 [Signature page to the Amended
and Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights
Agreement as of the date stated in the introductory clause. 
  

			
	INVESTOR
	
	ECOR1 CAPITAL FUND QUALIFIED, L.P.
		
	By	 	/s/ Oleg Nodelman
	Name:	 	Oleg Nodelman
	Title:    Managing Director, EcoR1 Capital, LLC

  
 [Signature page to the Amended
and Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights
Agreement as of the date stated in the introductory clause. 
  

			
	INVESTOR
	
	ECOR1 SPECIAL OPPORTUNITY FUND II, L.P.
		
	By:	 	/s/ Oleg Nodelman
	Name:	 	Oleg Nodelman
	Title:   Managing Director, EcoR1 Capital, LLC

  
 [Signature page to the Amended
and Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights
Agreement as of the date stated in the introductory clause. 
  

			
	INVESTOR
	
	ECOR1 SPECIAL OPPORTUNITY FUND II, L.P.
		
	By:	 	/s/ Oleg Nodelman
	Name:	 	Oleg Nodelman
	Title:   Managing Director, EcoR1 Capital, LLC

  
 [Signature page to the Amended
and Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights
Agreement as of the date stated in the introductory clause. 
  

			
	INVESTOR
	
	FORESITE CAPITAL FUND III, L.P.
	
	BY:      Foresite Capital Management III, LLC, its General Partner
		
	By:	 	/s/ Dennis D. Ryan
	Name:	 	Dennis D. Ryan
	Title:    Chief Financial Officer

  
 [Signature page to the Amended
and Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights Agreement as of the
date stated in the introductory clause. 
  

			
	INVESTOR
	
	THE COLUMN GROUP II, LP
		
	By:	 	    The Column Group II GP, LP
	Its General Partner
		
	By:	 	The Column Group, LLC
	Its General Partner
		
	By:	 	/s/ Peter Svennilson

 
			
	Name:	 	Peter Svennilson
	Title:	 	Managing Member

  
 [Signature page to the Amended
and Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights Agreement as of the
date stated in the introductory clause. 
  

			
	INVESTOR
	
	HARTFORD HEALTHCARE ENDOWMENT, LLC

 
			
		
	By:	 	 /s/ David Holmgren

			
		
	Name:	 	 David Holmgren

		
	Title:	 	 Chief Investment Officer

  
 [Signature page to the Amended
and Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights Agreement as of the
date stated in the introductory clause. 
  

			
	INVESTOR
	
	HARTFORD HEALTHCARE CORPDEFINED BENEFIT MASTER TRUST
		
	By:	 	 /s/ David Holmgren

			
		
	Name:	 	 David Holmgren

		
	Title:	 	 Chief Investment Officer

  
 [Signature page to the Amended
and Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights Agreement as of the
date stated in the introductory clause. 
  

			
	INVESTOR
	
	OrbiMed Private Investments VI, LP
		
	By:	 	OrbiMed Capital GP VI LLC,
		 	its General Partner
		
	By:	 	OrbiMed Advisors LLC,
		 	its Managing Member
		
	By:	 	/s/ Carl Gordon
		
	Name:	 	Carl Gordon
		
	Title:	 	Managing Partner

  
 [Signature page to the Amended
and Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights Agreement as of the
date stated in the introductory clause. 
  

			
	INVESTOR
	
	TOPSPIN BIOTECH FUND II, LP
	TOPSPIN FUND, LP
		
	By:    	 	 /s/ Steven J. Winick

		 	Name: Steven J. Winick
		 	Title: Managing Director

  
 [Signature page to the Amended
and Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights Agreement as of the
date stated in the introductory clause. 
  

			
	INVESTOR
	
	KRAVIS INVESTMENT PARTNERS, LLC
		
	By:    	 	 /s/ Henry R. Kravis

	Name: Henry R. Kravis
	Title: Managing Member

  
 [Signature page to the Amended
and Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights Agreement as of the
date stated in the introductory clause. 
  

							
		 		  	INVESTOR
			
		 		  	INVOPPS IV, L.P.
		 		  	By InvOpps GP W, L.L.C., its General Partner
				
		 		  	Signature:	 	 /s/ Sacha Lainovic

		 		  	Name: Sacha Lainovic
		 		  	Title: Managing Member
			
		 		  	INVOPPS IV US, L.P.
		 		  	By InvOpps GP W, L.L.C., its General Partner
				
		 		  	Signature:	 	 /s/ Sacha Lainovic

		 		  	Name: Sacha Lainovic
		 		  	Title: Managing Member

  
 [Signature page to the Amended and
Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights Agreement as of the
date stated in the introductory clause. 
  

					
		  	INVESTOR
		
		  	TAIHO VENTURES, LLC
			
		  	By:	 	 /s/ Sakae Asanuma

		
		  	Name:   Sakae Asanuma
		
		  	Title:   President

  
 [Signature page to the Amended and
Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights Agreement as of the
date stated in the introductory clause. 
  

			
	INVESTOR
	
	CASDIN PARTNERS MASTER FUND, L.P.
	
	By: Casdin Partners GP, LLC, its General Partner
		
	By: 	 	 /s/ Eli Casdin

 

			
	Name:   Eli Casdin
	Title:   Managing Member

  
 [Signature page to the Amended
and Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights Agreement as of the
date stated in the introductory clause. 
  

			
	INVESTOR
	
	FIDELITY MT. ‘VERNON STREET TRUST:
	FIDELITY SERIES GROWTH COMPANY
	FUND
		
	By:	 	 /s/ Colm Hogan

 
			
		
	Name:	 	 Colm Hogan

		
	Title:	 	 Authorized Signatory

			
	
	Address for future notifications:
	
	 Mag & Co.
 c/o Brown
Brothers Harriman & Co.

	 Attn:   Corporate Actions/Vault

140 Broadway

	New York, NY 10005

  
 [Signature page to the Amended
and Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights Agreement as of the
date stated in the introductory clause. 
  

			
	INVESTOR
	
	 FIDELITY MT. ‘VERNON STREET TRUST:

FIDELITY GROWTH COMPANY FUND

 
			
		
	By:  	 	/s/ Colm Hogan

 
			
		
	Name: 	 	Colm Hogan
		
	Title:	 	Authorized Signatory

  

	
	Address for future notifications:
	
	 BNY MELLON
 ONE BNY MELLON CENTER

500 GRANT STREET AIM 151-2700

PITTSBURGH, PA 15258

  
 [Signature page to the Amended
and Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights Agreement as of the
date stated in the introductory clause. 
  

			
	INVESTOR
	
	 FIDELITY GROWTH COMPANY

COMMINGLED POOL

	
	By: Fidelity Management Trust Company, as Trustee

 
			
		
	By:	 	/s/ Colm Hogan
		
	Name:	 	Colm Hogan
		
	Title:	 	Authorized Signatory

  

	
	Address for future notifications:
	
	 Mag & Co.
 c/o Brown Brothers
Harriman & Co.
 Attn: Corporate Actions /Vault
 140
Broadway
 New York, NY 10005

  
 [Signature page to the Amended
and Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights Agreement as of the
date stated in the introductory clause. 
  

	
	INVESTOR
	
	JACOB CHACKO
	
	/s/ Jacob Chacko
	Jacob Chacko

  
 [Signature page to the Amended
and Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights Agreement as of the
date stated in the introductory clause. 
  

			
	INVESTOR
	
	 CORRELATION VENTURES II, L.P.

for itself and as nominee

	
	 By: CORRELATION VENTURES II, GP, LLC

Its: General Partner

 
			
		
	By:  	 	/s/ David E. Coats

 
			
	Name:	 	David E. Coats

 
			
	Title: 	 	Managing Member

  
 [Signature page to the Amended
and Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights Agreement as of the
date stated in the introductory clause. 
  

			
	INVESTOR
	
	IRVING INVESTORS PRIVATES HPC XII, LLC
		
	By:	 	/s/ Jeremy Abelson
	Name:	 	Jeremy Abelson
	Title:	 	Member

  
 [Signature page to the Amended
and Restated Investors’ Rights Agreement] 

 The parties are signing this Amended and Restated Investors’ Rights Agreement as of e
date stated in the introductory clause. 
  

			
	INVESTOR
	
	M. KINGNGDON OFFSHORE MASTER FUND, L.P.
	
	By: Kingdon Capital Management, L.L.C.,
as agent and investment adviser
		
	By: 	 	/s/ William Walsh, CFO

  
 [Signature page to the Amended
and Restated Investors’ Rights Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00305-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00305-of-00352.parquet"}]]